Ayala Pharmaceuticals Inc (ADXS)

[equaloppforall]

I agree with Ignatius and Gantor completely.

But I would suggest to any long here who is frustrated that they get access to L2 (TD Ameritrade's ThinkorSwim is a great option). You will be able to verify for yourself that a vast majority of today's trading is pure, unadulterated HFT. 100, 200 and 300 share algo trades constituting about 80-85% of the volume (selling and covering them over and over progressively lower), interspersed with actual trades.

While short hedge funds attack most small cap biotechs mercilessly, there are very few biotechs that are attacked based on information that has not even been officially PR'd by the company yet. For example, attacking the results of the FAWCETT study today (even though it met the criteria for moving to stage 2 in a very sick population of patients).

The hedge fund shorts follow ADXS closely; they scour message boards for retail sentiment, write deliberately vague and misleading articles about its stock and science (think the yahoo article this last Friday), pre-program their algos to crash the stock (think the GOG results on September 17, 2015, Investor Day in June 2017 etc.).

These are facts about ADXS' stock and the manipulation occurring in it does not need additional proof if one is logical and has eyes open (once again, kindly watch L2). But I do agree that the only way to get past this short stranglehold, particularly in this price range, is for the company to release monster news - preferably a multi-hundred million partnership plus a series of regulatory breakthroughs.